Article

The Immune System’s Role in Glymphatic System Clearance and Alzheimer’s Disease Risk: A Csf Proteome-wide Study

2024-10-18

Abstract excerpt

<title>Abstract</title> <p>Background: The emerging evidence of the role of the glymphatic system (GS) in Alzheimer’s disease (AD) provides new opportunities for intervention from the earliest stages of the disease. The aim of the study is to evaluate the efficacy of GS in AD to identify new disease biomarkers. <h4>Methods:</h4> We performed a two-stage proteomic study to evaluate the GS health using intravenous...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: abfbaa1c-0957-5bb2-8d04-d6d054b5f911
DOI: 10.21203/rs.3.rs-4997367/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

The Immune System’s Role in Glymphatic System Clearance and Alzheimer’s Disease Risk: A Csf Proteome-wide StudyDOI 10.21203/rs.3.rs-4997367/v1Read

Systematic proteomics in Autosomal dominant Alzheimer’s disease reveals decades-early changes of CSF proteins in neuronal death, and immune pathwaysSemantic proximity Read

Proteome-wide association study identifies novel Alzheimer's disease- associated proteinsSemantic proximity Read

Integrative analyses of neuroimaging, clinical, and multi-omics data identified meaningful Alzheimer’s disease progression subtypesSemantic proximity Read

Proteomic Subtyping of Alzheimer’s Disease CSF links Blood-Brain Barrier Dysfunction to Reduced levels of Tau and Synaptic BiomarkersSemantic proximity Read

Pathophysiological subtypes of Alzheimer’s disease based on cerebrospinal fluid proteomicsSemantic proximity Read

Proteome profiling in cerebrospinal fluid reveals novel biomarkers of Alzheimer's diseaseSemantic proximity Read

Pathophysiological subtypes of Alzheimer’s disease based on cerebrospinal fluid proteomicsSemantic proximity Read

Identification of conserved proteomic networks in neurodegenerative dementiaSemantic proximity Read

Alzheimer’s disease CSF biomarkers correlate with early pathology and alterations in neuronal and glial gene expressionSemantic proximity Read

CSF proteome profiling across the Alzheimer’s disease spectrum reflects the multifactorial nature of the disease and identifies specific biomarker panelsSemantic proximity Read

Cerebrospinal fluid proteomics in patients with Alzheimer’s disease reveals five molecular subtypes with distinct genetic risk profilesSemantic proximity Read

Proteomics analysis of plasma from middle-aged adults identifies protein markers of dementia risk in later lifeSemantic proximity Read